Modulation of phosphoinositide–protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness

Merikangas, 2002, Future of genetics of mood disorders research, Biol. Psychiatry, 52, 457, 10.1016/S0006-3223(02)01471-3 Casebolt, 1989, Long-term lithium treatment selectively reduces receptor-coupled inositol phospholipid hydrolysis in rat brain, Biol. Psychiatry, 25, 329, 10.1016/0006-3223(89)90180-7 Lenox, 1991, Muscarinic receptor regulation and protein kinase C: sites for the action of chronic lithium in the hippocampus, Psychopharmacol. Bull., 27, 191 O’Donnell, 2003, Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain, Eur. Neuropsychopharmacol., 13, 199, 10.1016/S0924-977X(03)00011-7 van Calker, 2000, The high affinity inositol transport system—implications for the pathophysiology and treatment of bipolar disorder, Bipolar. Disord., 2, 102, 10.1034/j.1399-5618.2000.020203.x Casebolt, 1991, Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation, Biol. Psychiatry, 29, 233, 10.1016/0006-3223(91)91285-Y Lenox, 1992, Chronic lithium administration alters a prominent PKC substrate in rat hippocampus, Brain Res., 570, 333, 10.1016/0006-8993(92)90598-4 Manji, 1999, Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness, Biol. Psychiatry, 46, 1328, 10.1016/S0006-3223(99)00235-8 Manji, 1993, Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme, J. Neurochem., 61, 2303, 10.1111/j.1471-4159.1993.tb07474.x Manji, 1996, Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol, Neuropsychopharmacology, 15, 370, 10.1016/0893-133X(95)00243-7 Morishita, 1994, The direct effect of lithium and carbamazepine on protein kinase C in rat brain, Jpn. J. Psychiatry Neurol., 48, 123 Wang, 2001, Lithium treatment inhibits protein kinase C translocation in rat brain cortex, Psychopharmacology, 158, 80, 10.1007/s002130100834 Wang, 1989, Lithium inhibition of protein kinase C activation-induced serotonin release, Psychopharmacology, 99, 213, 10.1007/BF00442810 Bazinet, 2006, Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: Relevance to bipolar disorder, Biol. Psychiatry, 59, 401, 10.1016/j.biopsych.2005.07.024 Chang, 1998, Chronic lithium treatment decreases brain phospholipase A2 activity, Neurochem. Res., 23, 887, 10.1023/A:1022415113421 Chang, 2001, Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers, J. Neurochem., 77, 796, 10.1046/j.1471-4159.2001.00311.x Ghelardoni, 2004, Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain, Biol. Psychiatry, 56, 248, 10.1016/j.biopsych.2004.05.012 Friedel, 1981, Actions of neuroleptics on the acetylcholine-induced phospholipid effect in rat neostriatal homogenates, Neuropharmacology, 20, 925, 10.1016/0028-3908(81)90022-8 Edwards, 1991, The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin, Brain Res., 545, 276, 10.1016/0006-8993(91)91296-D Hietala, 2001, Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment, Psychopharmacology, 157, 180, 10.1007/s002130100814 Li, 1992, Effects of chronic nicotine and haloperidol administration on muscarinic receptor-mediated phosphoinositide turnover in rat brain slices, Psychopharmacology, 109, 248, 10.1007/BF02245510 Schatzman, 1981, Phospholipid-sensitive calcium-dependent protein kinase: inhibition by antipsychotic drugs, Biochem. Biophys. Res. Commun., 98, 669, 10.1016/0006-291X(81)91166-9 Zhang, 1999, The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors, Psychopharmacology, 141, 267, 10.1007/s002130050834 Dwivedi, 1999, Effects of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C (PKC) and phosphoinositide-specific phospholipase C (PI-PLC) activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain, J. Pharmacol. Exp. Ther., 291, 688 Kumar, 1997, Inhibition of rat brain protein kinase C by lipid soluble psychotropics, Neurochem. Res., 22, 1, 10.1023/A:1027332000569 Mori, 1980, Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase, J. Biol. Chem., 255, 8378, 10.1016/S0021-9258(18)43501-6 Kanterman, 1991, Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells, Mol. Pharmacol., 39, 364 Qu, 2003, Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (±)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI), Neuropsychopharmacology, 28, 244, 10.1038/sj.npp.1300022 Xing, 1996, Protein kinase C-dependent activation of cytosolic phospholipase A2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in Madin-Darby canine kidney cells, J. Clin. Invest., 97, 1302, 10.1172/JCI118546 Felder, 1990, A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C, J. Pharmacol. Exp. Ther., 255, 1140 Dwivedi, 2002, Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC beta 1 isozyme in rat brain, Neuropharmacology, 43, 1269, 10.1016/S0028-3908(02)00253-8 Dyck, 1989, Effects of antidepressant drugs on inositol phospholipid hydrolysis in rat cerebral cortical slices, Neurochem. Res., 14, 1047, 10.1007/BF00965609 Kendall, 1985, 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants, J. Pharmacol. Exp. Ther., 233, 473 Kawanami, 1992, Influence of stress and antidepressant treatment on 5-HT-stimulated phosphoinositide hydrolysis in rat brain, Eur. J. Pharmacol., 216, 385, 10.1016/0014-2999(92)90435-7 Pandey, 1991, Effect of desipramine on inositol phosphate formation and inositol phospholipids in rat brain and human platelets, Psychopharmacol. Bull., 27, 255 Sanders-Bush, 1989, Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system, Psychopharmacology, 99, 64, 10.1007/BF00634454 Subhash, 1997, Imipramine-induced changes in 5-HT2 receptor sites and inositoltrisphosphate levels in rat brain, Neurochem. Res., 22, 1095, 10.1023/A:1027357000511 Mann, 1995, Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine, Br. J. Pharmacol., 115, 595, 10.1111/j.1476-5381.1995.tb14973.x Morishita, 1997, Effect of the tricyclic antidepressant desipramine on protein kinase C in rat brain and rabbit platelets in vitro, Psychiatry Clin. Neurosci., 51, 249, 10.1111/j.1440-1819.1997.tb02592.x Gray, 2001, Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists, Brain Res. Bull., 56, 441, 10.1016/S0361-9230(01)00623-2 Subhash, 2003, Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain, Neurochem. Int., 43, 603, 10.1016/S0197-0186(03)00097-4 Kucia, 2003, Effect of antidepressants on the phospholipase A2 activity in plasma membranes of the rat brain cortex, Pol. J. Pharmacol., 55, 5 Das, 1992, Inositol phospholipid turnover in platelets of schizophrenic patients, Prostaglandins Leukot. Essent. Fatty Acids, 46, 65, 10.1016/0952-3278(92)90061-M Das, 1994, Elevated platelet phosphatidylinositol bisphosphate in mediated schizophrenics, Schizophr. Res., 12, 265, 10.1016/0920-9964(94)90037-X Das, 1995, Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain, Biochem. Biophys. Res. Commun., 212, 375, 10.1006/bbrc.1995.1980 DeLisi, 1981, Increased whole blood serotonin concentrations in chronic schizophrenic patients, Arch. Gen. Psychiatry, 38, 647, 10.1001/archpsyc.1981.01780310047004 Ereshefsky, 1996, Serotonin-mediated increase in cytosolic [Ca++] in platelets of risperidone-treated schizophrenia patients, Psychopharmacol. Bull., 32, 101 Gattaz, 1995, Increased platelet phospholipase A2 activity in schizophrenia, Schizophr. Res., 16, 1, 10.1016/0920-9964(94)00060-L Jackman, 1983, Platelet serotonin levels in schizophrenia: relationship to race and psychopathology, Biol. Psychiatry, 18, 887 Kaiya, 1989, Accumulation of diacylgylcerol in platelet phosphoinositide turnover in schizophrenia: a biological marker of good prognosis?, Biol. Psychiatry, 26, 669, 10.1016/0006-3223(89)90101-7 Ripova, 1997, Phospholipids and calcium alterations in platelets of schizophrenic patients, Physiol. Res., 46, 59 Ripova, 1999, Phosphoinositide signalling system in platelets of schizophrenic patients and the effect of neuroleptic therapy, Prostaglandins Leukot. Essent. Fatty Acids, 61, 125, 10.1054/plef.1999.0081 Stahl, 1983, Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders, Am. J. Psychiatry, 140, 26, 10.1176/ajp.140.1.26 Yao, 1992, Increased turnover of platelet phosphatidylinositol in schizophrenia, Prostaglandins Leukot. Essent. Fatty Acids, 46, 39, 10.1016/0952-3278(92)90057-P Yao, 1994, Platelet aggregation and dense granule secretion in schizophrenia, Psychiatry Res., 54, 13, 10.1016/0165-1781(94)90061-2 Brown, 1993, Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania, Am. J. Psychiatry, 150, 1252, 10.1176/ajp.150.8.1252 Dubovsky, 1991, Elevated platelet intracellular calcium concentration in bipolar depression, Biol. Psychiatry, 29, 441, 10.1016/0006-3223(91)90266-O Dubovsky, 1992, Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients, Am. J. Psychiatry, 149, 118, 10.1176/ajp.149.1.118 Friedman, 1993, Altered platelet protein kinase C activity in bipolar affective disorder, manic episode, Biol. Psychiatry, 33, 520, 10.1016/0006-3223(93)90006-Y Hahn, 2005, Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients, J. Psychiatr. Res., 39, 355, 10.1016/j.jpsychires.2004.10.007 Kusumi, 1992, Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders, Biol. Psychiatry, 32, 731, 10.1016/0006-3223(92)90305-J Soares, 1997, Platelet membrane phosphatidylinositol-4,5-bisphosphate alterations in bipolar disorder—evidence from a single case study, Psychiatry Res., 69, 197, 10.1016/S0165-1781(96)03022-3 Soares, 1999, Platelet membrane phospholipids in euthymic bipolar disorder patients: are they affected by lithium treatment?, Biol. Psychiatry, 45, 453, 10.1016/S0006-3223(98)00048-1 Soares, 2000, Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study, Psychiatry Res., 95, 109, 10.1016/S0165-1781(00)00175-X Soares, 2000, Effects of lithium on platelet membrane phosphoinositides in bipolar disorder patients: a pilot study, Psychopharmacology, 149, 12, 10.1007/s002139900341 Soares, 2001, Increased platelet membrane phosphatidylinositol-4,5-bisphosphate in drug-free depressed bipolar patients, Neurosci. Lett., 299, 150, 10.1016/S0304-3940(00)01775-4 Suzuki, 2001, Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorder?, J. Affect Disord., 64, 291, 10.1016/S0165-0327(00)00221-4 Suzuki, 2003, Altered 5-HT-induced calcium response in the presence of staurosporine in blood platelets from bipolar disorder patients, Neuropsychopharmacology, 28, 1210, 10.1038/sj.npp.1300159 Wang, 1999, Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients, J. Psychiatr. Res., 33, 171, 10.1016/S0022-3956(98)90057-7 Yamawaki, 1996, Enhanced calcium response to serotonin in platelets from patients with affective disorders, J. Psychiatry Neurosci., 21, 321 Alvarez, 1999, Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine, Clin. Pharmacol. Ther., 66, 617, 10.1053/cp.1999.v66.103402001 Delisi, 1998, Platelet cytosolic calcium responses to serotonin in depressed patients and controls: relationship to symptomatology and medication, Biol. Psychiatry, 43, 327, 10.1016/S0006-3223(97)00377-6 Delisi, 1999, Platelet cytosolic calcium hyperresponsivity to serotonin in patients with hypertension and depressive symptoms, Biol. Psychiatry,, 45, 1035, 10.1016/S0006-3223(98)00157-7 Dwivedi, 1998, Elevated [3H]inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients, Psychopharmacology, 138, 47, 10.1007/s002130050644 Eckert, 1993, Elevated intracellular calcium levels after 5-HT2 receptor stimulation in platelets of depressed patients, Biol. Psychiatry, 34, 565, 10.1016/0006-3223(93)90201-N Karege, 1996, Platelet phosphoinositide signaling system: an overstimulated pathway in depression, Biol. Psychiatry, 39, 697, 10.1016/0006-3223(95)00187-5 Konopka, 1996, Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients, Biol. Psychiatry, 39, 708, 10.1016/0006-3223(95)00189-1 Kusumi, 1991, Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients, Biol. Psychiatry, 30, 310, 10.1016/0006-3223(91)90114-2 Kusumi, 1994, Serotonin-induced platelet intracellular calcium mobilization in depressed patients, Psychopharmacology, 113, 322, 10.1007/BF02245204 Mikuni, 1991, Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients, Prog. Neuropsychopharmacol. Biol. Psychiatry, 15, 49, 10.1016/0278-5846(91)90040-8 Mori, 1991, Platelet alpha-2 adrenergic receptor-mediated phosphoinositide responses in endogenous depression, Life Sci., 48, 741, 10.1016/0024-3205(91)90088-S Morishita, 1999, Different effect of desipramine on protein kinase C in platelets between bipolar and major depressive disorders, Psychiatry Clin. Neurosci., 53, 11, 10.1046/j.1440-1819.1999.00479.x Pandey, 1998, Protein kinase C in platelets of depressed patients, Biol. Psychiatry, 44, 909, 10.1016/S0006-3223(97)00535-0 Pandey, 2001, Hyperactive phosphoinositide signaling pathway in platelets of depressed patients: effect of desipramine treatment, Psychiatry Res., 105, 23, 10.1016/S0165-1781(01)00337-7 Plein, 2000, Changes in the platelet intracellular calcium response to serotonin in patients with major depression treated with electroconvulsive therapy: state or trait marker status, Int. Clin. Psychopharmacol., 15, 93, 10.1097/00004850-200015020-00005 Rehavi, 1993, Interaction between antidepressants and phosphoinositide signal transduction system in human platelets, Biol. Psychiatry, 33, 40, 10.1016/0006-3223(93)90276-J Tomiyoshi, 1999, Serotonin-induced platelet intracellular Ca2+ responses in untreated depressed patients and imipramine responders in remission, Biol. Psychiatry, 45, 1042, 10.1016/S0006-3223(98)00171-1 Wasserman, 2004, Chronic lithium treatment attenuates intracellular calcium mobilization, Neuropsychopharmacology, 29, 759, 10.1038/sj.npp.1300400 Friedman, 1996, Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects, J. Neurochem., 67, 1145, 10.1046/j.1471-4159.1996.67031145.x Jope, 1996, The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain, J. Neurochem., 66, 2402, 10.1046/j.1471-4159.1996.66062402.x Mathews, 1997, Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder, Biol. Psychiatry, 41, 649, 10.1016/S0006-3223(96)00113-8 Shimon, 1997, Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder, Am. J. Psychiatry, 154, 1148, 10.1176/ajp.154.8.1148 Moore, 1999, Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness, Am. J. Psychiatry, 156, 1902, 10.1176/ajp.156.12.1902 Wang, 1996, Enhanced protein kinase C activity and translocation in bipolar affective disorder brains, Biol. Psychiatry, 40, 568, 10.1016/0006-3223(95)00611-7 Wang, 2001, Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder, Biol. Psychiatry, 50, 364, 10.1016/S0006-3223(01)01147-7 Dean, 1997, Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia, J. Neural. Transm., 104, 1371, 10.1007/BF01294738 Jope, 1998, Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence, J. Neurochem., 70, 763, 10.1046/j.1471-4159.1998.70020763.x Lin, 1999, Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia, Biol. Psychiatry, 46, 1665, 10.1016/S0006-3223(99)00036-0 Shimon, 1998, Inositol levels are decreased in postmortem brain of schizophrenic patients, Biol. Psychiatry, 44, 428, 10.1016/S0006-3223(98)00071-7 Coull, 2000, Altered brain protein kinase C in depression: a post-mortem study, Eur. Neuropsychopharmacol., 10, 283, 10.1016/S0924-977X(00)00084-5 Coull, 2000, Post-mortem studies of brain phosphatidylinositol hydrolysis in depression and the effect of antidepressant treatment, Int. J. Neuropsychopharmacol., 3, 109, 10.1017/S1461145700001851 Pacheco, 1996, Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain, Brain Res., 723, 37, 10.1016/0006-8993(96)00207-7 Pandey, 2003, Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression, J. Psychiatr. Res, 37, 421, 10.1016/S0022-3956(03)00047-5 Silverstone, 2005, Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings, Bipolar. Disord., 7, 1, 10.1111/j.1399-5618.2004.00174.x Kumar, 2002, Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy, Am. J. Psychiatry, 159, 630, 10.1176/appi.ajp.159.4.630 Wyckoff, 2003, Magnetization transfer imaging and magnetic resonance spectroscopy of normal-appearing white matter in late-life major depression, J. Magn. Reson. Imaging, 18, 537, 10.1002/jmri.10400 Binesh, 2004, Neurochemistry of late-life major depression: a pilot two-dimensional MR spectroscopic study, J. Magn. Reson. Imaging, 20, 1039, 10.1002/jmri.20214 Gruber, 2003, Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla, Invest. Radiol., 38, 403, 10.1097/01.rli.0000073446.43445.20 Bluml, 1999, Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo, J. Comput. Assist. Tomogr., 23, 272, 10.1097/00004728-199903000-00017 Block, 2000, Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study, Neurosci. Lett., 289, 147, 10.1016/S0304-3940(00)01264-7 Delamillieure, 2002, Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex, Schizophr. Bull., 28, 329, 10.1093/oxfordjournals.schbul.a006942 Vaughan, 1998, The regulation of neurotransmitter secretion by protein kinase C, Mol. Neurobiol., 18, 125, 10.1007/BF02914269 Apparsundaram, 1998, Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins, J. Pharmacol. Exp. Ther., 287, 744 Loder, 2003, The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines, J. Biol. Chem., 278, 22168, 10.1074/jbc.M301845200 Ramamoorthy, 1998, Phosphorylation and regulation of antidepressant-sensitive serotonin transporters, J. Biol. Chem., 273, 2458, 10.1074/jbc.273.4.2458 Namkung, 2004, Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor, J. Biol. Chem., 279, 49533, 10.1074/jbc.M408319200 Bhattacharyya, 2002, Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms, Proc. Natl. Acad. Sci. USA, 99, 14470, 10.1073/pnas.212517999 Liao, 2001, Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current, Mol. Pharmacol., 59, 960, 10.1124/mol.59.5.960 McDonald, 2001, Identification of protein kinase C phosphorylation sites within the AMPA receptor GluR2 subunit, Neuropharmacology, 41, 672, 10.1016/S0028-3908(01)00129-0 Tingley, 1997, Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies, J. Biol. Chem., 272, 5157, 10.1074/jbc.272.8.5157 Beckmann, 1992, Nuclear substrates of protein kinase C, Eur. J. Biochem., 210, 45, 10.1111/j.1432-1033.1992.tb17388.x Hocevar, 1993, Identification of protein kinase C (PKC) phosphorylation sites on human lamin B. Potential role of PKC in nuclear lamina structural dynamics, J. Biol. Chem., 268, 7545, 10.1016/S0021-9258(18)53210-5 Huang, 2004, Phorbol ester promotes histone H3-Ser10 phosphorylation at the LDL receptor promoter in a protein kinase C-dependent manner, J. Lipid Res., 45, 1519, 10.1194/jlr.M400088-JLR200 Ohtani, 1995, Involvement of protein kinase C in Ca(2+)-signaling pathways to activation of AP-1 DNA-binding activity evoked via NMDA- and voltage-gated Ca2+ channels, J. Neurochem., 65, 605, 10.1046/j.1471-4159.1995.65020605.x Mobarak, 2000, The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells, Mol. Biol. Cell, 11, 3191, 10.1091/mbc.11.9.3191 Wein, 2003, The 3′-UTR of the mRNA coding for the major protein kinase C substrate MARCKS contains a novel CU-rich element interacting with the mRNA stabilizing factors HuD and HuR, Eur. J. Biochem., 270, 350, 10.1046/j.1432-1033.2003.03396.x Ventura, 2001, Protein kinase C control of gene expression, Crit. Rev. Eukaryot. Gene Expr., 11, 243, 10.1615/CritRevEukarGeneExpr.v11.i1-3.120 Asotra, 1993, Protein kinase C activity modulates myelin gene expression in enriched oligodendrocytes, J. Neurosci. Res., 34, 571, 10.1002/jnr.490340509 Avossa, 1993, Transient reversion of O4+ GalC- oligodendrocyte progenitor development in response to the phorbol ester TPA, J. Neurosci. Res., 34, 113, 10.1002/jnr.490340112 Pouly, 1997, Demyelination induced by protein kinase C-activating tumor promoters in aggregating brain cell cultures, J. Neurosci. Res., 49, 121, 10.1002/(SICI)1097-4547(19970715)49:2<121::AID-JNR1>3.0.CO;2-B Paschen, 2000, Role of calcium in neuronal cell injury: which subcellular compartment is involved?, Brain Res. Bull., 53, 409, 10.1016/S0361-9230(00)00369-5 Ayuso-Gutierrez, 1997, Factors influencing relapse in the long-term course of schizophrenia, Schizophr. Res., 28, 199, 10.1016/S0920-9964(97)00131-X Robinson, 1999, Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder, Arch. Gen. Psychiatry, 56, 241, 10.1001/archpsyc.56.3.241 Baldessarini, 1999, Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications, Bipolar. Disord., 1, 17, 10.1034/j.1399-5618.1999.10106.x Cavanagh, 2004, Relapse into mania or depression following lithium discontinuation: a 7-year follow-up, Acta. Psychiatr. Scand., 109, 91, 10.1046/j.1600-0447.2003.00274.x Geddes, 2003, Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review, Lancet, 361, 653, 10.1016/S0140-6736(03)12599-8 McPhail, 1984, A potential second messenger role for unsaturated fatty acids: activation of Ca2+-dependent protein kinase, Science, 224, 622, 10.1126/science.6231726 Miyake, 1983, Membrane phospholipid turnover in signal transduction; protein kinase C and mechanism of action of tumor promoters, Princess Takamatsu Symp., 14, 167 Carver, 2001, The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects, Brain Res. Bull., 56, 79, 10.1016/S0361-9230(01)00551-2 Connor, 1990, Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys, J. Lipid Res., 31, 237, 10.1016/S0022-2275(20)43209-2 Favreliere, 1998, Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum, Lipids, 33, 401, 10.1007/s11745-998-0221-y Lee, 1991, Molecular species of diacylglycerols and phosphoglycerides and the postmortem changes in the molecular species of diacylglycerols in rat brains, J. Neurochem., 56, 370, 10.1111/j.1471-4159.1991.tb08161.x Farooqui, 2004, Brain phospholipases A2: a perspective on the history, Prostaglandins Leukot. Essent. Fatty Acids, 71, 161, 10.1016/j.plefa.2004.03.004 Holian, 1992, Action of long-chain fatty acids on protein kinase C activity: comparison of ω-6 and omega-3 fatty acids, Anticancer Res., 12, 975 Naor, 1988, Calcium-independent activation of hypothalamic type I protein kinase C by unsaturated fatty acids, Mol. Endocrinol., 2, 1043, 10.1210/mend-2-11-1043 Sekiguchi, 1988, Mode of activation and kinetic properties of three distinct forms of protein kinase C from rat brain, J. Biochem., 103, 759, 10.1093/oxfordjournals.jbchem.a122343 Shearman, 1989, Selective activation of the gamma-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites, FEBS Lett., 243, 177, 10.1016/0014-5793(89)80125-5 Shearman, 1991, Protein kinase C subspecies in adult rat hippocampal synaptosomes. Activation by diacylglycerol and arachidonic acid, FEBS Lett., 279, 261, 10.1016/0014-5793(91)80163-W Shinomura, 1991, Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: its possible implications, Proc. Natl. Acad. Sci. USA, 88, 5149, 10.1073/pnas.88.12.5149 Speizer, 1991, Differential effects of omega-3 fish oils on protein kinase activities in vitro, Am. J. Physiol., 261, 109 Chen, 1992, Synergistic activation of type III protein kinase C by cis-fatty acid and diacylglycerol, Biochem. J., 282, 33, 10.1042/bj2820033 Koide, 1992, Isolation and characterization of the epsilon subspecies of protein kinase C from rat brain, Proc. Natl. Acad. Sci. USA, 89, 1149, 10.1073/pnas.89.4.1149 Lester, 1991, Arachidonic acid and diacylglycerol act synergistically to activate protein kinase C in vitro and in vivo, Biochem. Biophys. Res. Commun., 179, 1522, 10.1016/0006-291X(91)91745-X Murakami, 1985, Direct activation of purified protein kinase C by unsaturated fatty acids (oleate and arachidonate) in the absence of phospholipids and Ca2+, FEBS Lett., 192, 189, 10.1016/0014-5793(85)80105-8 Ogita, 1992, Isolation and characterization of delta-subspecies of protein kinase C from rat brain, Proc. Natl. Acad. Sci. USA, 89, 1592, 10.1073/pnas.89.5.1592 Sekiguchi, 1987, Three distinct forms of rat brain protein kinase C: differential response to unsaturated fatty acids, Biochem. Biophys. Res. Commun., 145, 797, 10.1016/0006-291X(87)91035-7 Shirai, 1998, Distinct effects of fatty acids on translocation of gamma- and epsilon-subspecies of protein kinase C, J. Cell Biol., 143, 511, 10.1083/jcb.143.2.511 Kochs, 1993, Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes, Eur. J. Biochem., 216, 597, 10.1111/j.1432-1033.1993.tb18179.x Macdonald, 1999, NGF-resistant PC12 cell death induced by arachidonic acid is accompanied by a decrease of active PKC zeta and nuclear factor kappa B, J. Neurosci. Res., 57, 219, 10.1002/(SICI)1097-4547(19990715)57:2<219::AID-JNR7>3.0.CO;2-C Muller, 1995, PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid, EMBO J., 14, 1961, 10.1002/j.1460-2075.1995.tb07188.x Eshete, 1998, Ca2+ modulation of cis-unsaturated fatty acid-induced mutant protein kinase C activity: indication of inhibitory Ca2+-binding site in protein kinase C-alpha, Biochem. J., 333, 215, 10.1042/bj3330215 Holian, 1991, Response of brain protein kinase C isozymes to ethyl oleate, an alcohol metabolite, Brain Res., 558, 98, 10.1016/0006-8993(91)90720-G Murakami, 1986, Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipids, J. Biol. Chem., 261, 15424, 10.1016/S0021-9258(18)66728-6 Verkest, 1988, Fatty acid activation of protein kinase C: dependence on diacylglycerol, Biochem. Biophys. Res. Commun., 152, 825, 10.1016/S0006-291X(88)80112-8 el Touny, 1990, Regulation of platelet protein kinase C by oleic acid. Kinetic analysis of allosteric regulation and effects on autophosphorylation, phorbol ester binding, and susceptibility to inhibition, J. Biol. Chem., 265, 16437, 10.1016/S0021-9258(17)46241-7 Khan, 1992, Activation of protein kinase C by oleic acid. Determination and analysis of inhibition by detergent micelles and physiologic membranes: requirement for free oleate,, J. Biol. Chem., 267, 3605, 10.1016/S0021-9258(19)50567-1 Khan, 1993, Selective regulation of protein kinase C isoenzymes by oleic acid in human platelets, J. Biol. Chem., 268, 5063, 10.1016/S0021-9258(18)53502-X Khan, 1995, Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C, Cell Signal, 7, 171, 10.1016/0898-6568(94)00089-T Mirnikjoo, 2001, Protein kinase inhibition by omega-3 fatty acids, J. Biol. Chem., 276, 10888, 10.1074/jbc.M008150200 Seung Kim, 2001, Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro, Mol. Psychiatry., 6, 246, 10.1038/sj.mp.4000837 Denys, 2001, Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells, Lipids, 36, 813, 10.1007/s11745-001-0789-2 Denys, 2005, n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway, J. Lipid Res., 46, 752, 10.1194/jlr.M400444-JLR200 Hardy, 1994, In vitro activation of rat brain protein kinase C by polyenoic very-long-chain fatty acids, J. Neurochem., 62, 1546, 10.1046/j.1471-4159.1994.62041546.x Fan, 2004, Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production, J. Immunol., 173, 6151, 10.4049/jimmunol.173.10.6151 Giorgione, 1998, Interfacial membrane properties modulate protein kinase C activation: role of the position of acyl chain unsaturation, Biochemistry, 37, 10956, 10.1021/bi980185a Goldberg, 1998, Synergistic effects of diacylglycerols and fatty acids on membrane structure and protein kinase C activity, Biochemistry, 37, 5623, 10.1021/bi9719354 Slater, 1996, Polyunsaturation in cell membranes and lipid bilayers and its effects on membrane proteins, Lipids, 31, S189, 10.1007/BF02637074 Bourre, 1992, Structural and functional importance of dietary polyunsaturated fatty acids in the nervous system, Adv. Exp. Med. Biol., 318, 211, 10.1007/978-1-4615-3426-6_18 Grandgirard, 1994, Incorporation of trans long-chain n-3 polyunsaturated fatty acids in rat brain structures and retina, Lipids, 29, 251, 10.1007/BF02536329 Suzuki, 1997, Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice, Int. J. Vitam Nutr. Res., 67, 272 Yeh, 1993, Maternal dietary fish oil enriches docosahexaenoate levels in brain subcellular fractions of offspring, J. Neurosci. Res., 35, 218, 10.1002/jnr.490350213 Abeliovich, 1993, Modified hippocampal long-term potentiation in PKC gamma-mutant mice, Cell, 75, 1253, 10.1016/0092-8674(93)90613-U Colley, 1990, Inhibition of protein kinase C blocks two components of LTP persistence, leaving initial potentiation intact, J. Neurosci., 10, 3353, 10.1523/JNEUROSCI.10-10-03353.1990 Hussain, 2005, A comparison of the roles of protein kinase C in long-term potentiation in rat hippocampal areas CA1 and CA3, Cell Mol. Neurobiol., 25, 649, 10.1007/s10571-005-4045-8 Hvalby, 1994, Specificity of protein kinase inhibitor peptides and induction of long-term potentiation, Proc. Natl. Acad. Sci. USA, 91, 4761, 10.1073/pnas.91.11.4761 Kleschevnikov, 2001, PKC activation rescues LTP from NMDA receptor blockade, Hippocampus, 11, 168, 10.1002/hipo.1034 Matsuyama, 1997, Long-term potentiation persistence greater in C57BL/6 than DBA/2 mice: predicted on basis of protein kinase C levels and learning performance, Brain Res., 763, 127, 10.1016/S0006-8993(97)00444-7 Ramakers, 1999, Differential changes in the phosphorylation of the protein kinase C substrates myristoylated alanine-rich C kinase substrate and growth-associated protein-43/B-50 following Schaffer collateral long-term potentiation and long-term depression, J. Neurochem., 73, 2175, 10.1046/j.1471-4159.1999.02175.x Serrano, 2005, Persistent phosphorylation by protein kinase Mzeta maintains late-phase long-term potentiation, J. Neurosci., 25, 1979, 10.1523/JNEUROSCI.5132-04.2005 Ramakers, 2000, Long term depression in the CA1 field is associated with a transient decrease in pre- and postsynaptic PKC substrate phosphorylation, J. Biol. Chem., 275, 28682, 10.1074/jbc.M003068200 Thiels, 2000, Protein phosphatase-mediated regulation of protein kinase C during long-term depression in the adult hippocampus in vivo, J. Neurosci., 20, 7199, 10.1523/JNEUROSCI.20-19-07199.2000 Fujita, 2001, Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices, Br. J. Pharmacol., 132, 1417, 10.1038/sj.bjp.0703970 Linden, 1987, Enhancement of long-term potentiation by cis-unsaturated fatty acid: relation to protein kinase C and phospholipase A2, J. Neurosci., 7, 3783, 10.1523/JNEUROSCI.07-11-03783.1987 Massicotte, 1990, Effect of bromophenacyl bromide, a phospholipase A2 inhibitor, on the induction and maintenance of LTP in hippocampal slices, Brain Res., 537, 49, 10.1016/0006-8993(90)90338-C Okada, 1989, Differential effects of phospholipase inhibitors in long-term potentiation in the rat hippocampal mossy fiber synapses and Schaffer/commissural synapses, Neurosci. Lett., 100, 141, 10.1016/0304-3940(89)90674-5 Williams, 1989, An in vitro study of the effect of lipoxygenase and cyclo-oxygenase inhibitors of arachidonic acid on the induction and maintenance of long-term potentiation in the hippocampus, Neurosci. Lett., 107, 301, 10.1016/0304-3940(89)90835-5 Bolshakov, 1995, Hippocampal long-term depression: arachidonic acid as a potential retrograde messenger, Neuropharmacology, 34, 1581, 10.1016/0028-3908(95)00127-R Fitzpatrick, 1994, Blockade of long-term depression in neonatal hippocampal slices by a phospholipase A2 inhibitor, Dev. Brain Res., 78, 81, 10.1016/0165-3806(94)90012-4 Normandin, 1996, Involvement of the 12-lipoxygenase pathway of arachidonic acid metabolism in homosynaptic long-term depression of the rat hippocampus, Brain Res., 730, 40, 10.1016/0006-8993(96)00428-3 Nishizaki, 1999, Arachidonic acid as a messenger for the expression of long-term potentiation, Biochem. Biophys Res. Commun., 254, 446, 10.1006/bbrc.1998.9961 Williams, 1989, Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus, Nature, 341, 739, 10.1038/341739a0 Reymann, 1988, Phorbol ester-induced hippocampal long-term potentiation is counteracted by inhibitors of protein kinase C, Exp. Brain Res., 71, 227, 10.1007/BF00247540 Breukel, 1997, Arachidonic acid inhibits uptake of amino acids and potentiates PKC effects on glutamate, but not GABA, exocytosis in isolated hippocampal nerve terminals, Brain Res., 773, 90, 10.1016/S0006-8993(97)00918-9 Coffey, 1994, Glutamate exocytosis and MARCKS phosphorylation are enhanced by a metabotropic glutamate receptor coupled to a protein kinase C synergistically activated by diacylglycerol and arachidonic acid, J. Neurochem., 63, 1303, 10.1046/j.1471-4159.1994.63041303.x Linden, 1986, A newly discovered protein kinase C activator (oleic acid) enhances long-term potentiation in the intact hippocampus, Brain Res., 379, 358, 10.1016/0006-8993(86)90790-0 Itokazu, 2000, Bidirectional actions of docosahexaenoic acid on hippocampal neurotransmissions in vivo, Brain Res., 862, 211, 10.1016/S0006-8993(00)02129-6 Young, 1998, Cancellation of low-frequency stimulation-induced long-term depression by docosahexaenoic acid in the rat hippocampus, Neurosci. Lett., 247, 198, 10.1016/S0304-3940(98)00272-9 Zhang, 2003, Effects of sodium valproate on synaptic plasticity in the CA1 region of rat hippocampus, Food Chem. Toxicol., 41, 1617, 10.1016/S0278-6915(03)00195-9 Wong, 1989, Dietary cis-fatty acids that increase protein F1 phosphorylation enhance spatial memory, Brain Res., 505, 302, 10.1016/0006-8993(89)91456-X Raygada, 1998, High maternal intake of polyunsaturated fatty acids during pregnancy in mice alters offsprings’ aggressive behavior, immobility in the swim test, locomotor activity and brain protein kinase C activity, J. Nutr., 128, 2505 Aid, 2003, Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus, J. Lipid Res., 44, 1545, 10.1194/jlr.M300079-JLR200 Delion, 1996, alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex, J. Neurochem., 66, 1582, 10.1046/j.1471-4159.1996.66041582.x Kodas, 2002, Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage, J. Lipid Res., 43, 1209, 10.1194/jlr.M200132-JLR200 Kodas, 2004, Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat, J. Neurochem., 89, 695, 10.1111/j.1471-4159.2004.02401.x Zimmer, 2000, Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids, J. Lipid Res., 41, 32, 10.1016/S0022-2275(20)32071-X Zimmer, 1998, Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study, Neurosci. Lett., 240, 177, 10.1016/S0304-3940(97)00938-5 Zimmer, 2002, The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids, Am. J. Clin. Nutr., 75, 662, 10.1093/ajcn/75.4.662 McNamara, 2006, Omega-3 fatty acid deficiency decreases dopamine D2 receptor binding and increases serotonin 5-HT2A receptor binding in the adult rat prefrontal cortex, Biol. Psychiatry, 59, S146 Calon, 2005, Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease, Eur. J. Neurosci., 22, 617, 10.1111/j.1460-9568.2005.04253.x Gerbi, 1998, Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids, J. Neurochem., 71, 732, 10.1046/j.1471-4159.1998.71020732.x Gerbi, 1999, Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats, J. Nutr., 129, 207, 10.1093/jn/129.1.207 Martinez, 1998, MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders, Neurology, 51, 26, 10.1212/WNL.51.1.26 Nordvik, 2000, Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients, Acta. Neurol. Scand., 102, 143, 10.1034/j.1600-0404.2000.102003143.x Salvati, 2002, Dietary prenatal lipids affect myelin gene expression in postnatal undernourished rats, Nutr. Neurosci., 5, 243, 10.1080/10284150290020754 Salvati, 2004, Stimulation of myelin proteolipid protein gene expression by eicosapentaenoic acid in C6 glioma cells, Neurochem. Int., 44, 331, 10.1016/S0197-0186(03)00172-4 Barcelo-Coblijn, 2003, Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids, Proc. Natl. Acad. Sci. USA, 100, 11321, 10.1073/pnas.1734008100 Kitajka, 2002, The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids, Proc. Natl. Acad. Sci. USA, 99, 2619, 10.1073/pnas.042698699 Medini, 1990, Diets rich in n-9, n-6 and n-3 fatty acids differentially affect the generation of inositol phosphates and of thromboxane by stimulated platelets, in the rabbit, Biochem. Pharmacol., 39, 129, 10.1016/0006-2952(90)90656-6 Nair, 2000, Suppression of inositol phosphate release by cardiac myocytes isolated from fish oil-fed pigs, Mol. Cell Biochem., 215, 57, 10.1023/A:1026538932590 Sperling, 1993, Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils, J. Clin. Invest., 91, 651, 10.1172/JCI116245 Hamilton, 2000, n-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues, Lipids, 35, 863, 10.1007/S11745-000-0595-x Murthy, 2002, Differential effects of n-3 fatty acid deficiency on phospholipid molecular species composition in the rat hippocampus, J. Lipid Res., 43, 611, 10.1016/S0022-2275(20)31491-7 Huang, 1989, Differential down-regulation of protein kinase C isozymes, J. Biol. Chem., 264, 4238, 10.1016/S0021-9258(19)84988-8 Touyarot, 2000, Calpain-PKC inter-relations in mouse hippocampus: a biochemical approach, Neurochem. Res., 25, 781, 10.1023/A:1007509322362 Young, 1987, Down-regulation of protein kinase C is due to an increased rate of degradation, Biochem. J., 244, 775, 10.1042/bj2440775 McNamara, 2006, Reductions in the principle brain omega-3 fatty acid, docosahexaenoic acid, in postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder, but not multiple sclerosis or Alzheimer's diseas, Biol. Psychiatry, 59, S30 Saito, 2002, Protein kinase C gamma (PKC gamma): function of neuron specific isotype, J. Biochem., 132, 683, 10.1093/oxfordjournals.jbchem.a003274 Yurko-Mauro, 1995, Dopamine receptor stimulation decreases cytosolic gamma protein kinase C immunoreactivity in rat hippocampal slices: evidence for increased Ca(2+)-dependent proteolysis, J. Neurochem., 65, 1622, 10.1046/j.1471-4159.1995.65041622.x McNamara, 2004, Acute restraint stress reduces protein kinase C gamma in the hippocampus of C57BL/6 but not DBA/2 mice, Neurosci. Lett., 368, 293, 10.1016/j.neulet.2004.07.028 Jardemark, 2003, Protein kinase C is involved in clozapine's facilitation of N-methyl-D-aspartate- and electrically evoked responses in pyramidal cells of the medial prefrontal cortex, Neuroscience, 118, 501, 10.1016/S0306-4522(02)00976-4 Sanchez-Perez, 2005, Serines 890 and 896 of the NMDA receptor subunit NR1 are differentially phosphorylated by protein kinase C isoforms, Neurochem. Int., 47, 84, 10.1016/j.neuint.2005.04.011 Suen, 1998, NMDA receptor subunits in the postsynaptic density of rat brain: expression and phosphorylation by endogenous protein kinases, Mol. Brain Res., 59, 215, 10.1016/S0169-328X(98)00157-0 Bowers, 1995, Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice, J. Neurochem., 64, 2737, 10.1046/j.1471-4159.1995.64062737.x Paylor, 1996, Developmental differences in place-learning performance between C57BL/6 and DBA/2 mice parallel the ontogeny of hippocampal protein kinase C, Behav. Neurosci., 110, 1415, 10.1037/0735-7044.110.6.1415 Moriguchi, 2000, Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration, J. Neurochem., 75, 2563, 10.1046/j.1471-4159.2000.0752563.x Moriguchi, 2003, Recovery of brain docosahexaenoate leads to recovery of spatial task performance, J. Neurochem., 87, 297, 10.1046/j.1471-4159.2003.01966.x Farber, 2003, The NMDA receptor hypofunction model of psychosis, Ann. NY Acad. Sci., 1003, 119, 10.1196/annals.1300.008 Goff, 2001, The emerging role of glutamate in the pathophysiology and treatment of schizophrenia, Am. J. Psychiatry, 158, 1367, 10.1176/appi.ajp.158.9.1367 Lahti, 2001, Effects of ketamine in normal and schizophrenic volunteers, Neuropsychopharmacology, 25, 455, 10.1016/S0893-133X(01)00243-3 Taniguchi, 1993, Interaction of myristoylated alanine-rich protein kinase C substrate (MARCKS) with membrane phospholipids, J. Biol. Chem, 268, 9960, 10.1016/S0021-9258(18)82158-5 Thelen, 1991, Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane, Nature, 351, 320, 10.1038/351320a0 McNamara, 2004, The myristoylated alanine-rich C kinase substrate: A lithium-regulated protein linking cellular signaling and cytoskeletal plasticity, Clin. Neurosci. Res, 4, 155, 10.1016/j.cnr.2004.09.008 Yoshida, 1997, Synaptic vesicle ultrastructural changes in the rat hippocampus induced by a combination of alpha-linolenate deficiency and a learning task, J. Neurochem, 68, 1261, 10.1046/j.1471-4159.1997.68031261.x Zimmer, 2000, Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex, Neurosci. Lett., 284, 25, 10.1016/S0304-3940(00)00950-2 Abou-Samra, 1986, Involvement of protein kinase C in the regulation of adrenocorticotropin release from rat anterior pituitary cells, Endocrinology, 118, 212, 10.1210/endo-118-1-212 Akita, 2000, Involvement of protein kinase C epsilon in thyrotropin-releasing hormone-stimulated phosphorylation of the myristoylated alanine-rich C kinase substrate in rat pituitary clonal cells, Electrophoresis, 21, 452, 10.1002/(SICI)1522-2683(20000101)21:2<452::AID-ELPS452>3.0.CO;2-L Kim, 2000, Inhibition of brain protein kinase C attenuates immobilization stress-induced plasma corticosterone levels in mice, Neurosci. Lett., 291, 69, 10.1016/S0304-3940(00)01376-8 Liu, 1994, Mol. Cell Endocrinol., 105, 217, 10.1016/0303-7207(94)90173-2 McNamara, 1999, Differential subcellular redistribution of protein kinase C isozymes in the rat hippocampus induced by kainic acid, J. Neurochem., 72, 1735, 10.1046/j.1471-4159.1999.721735.x Hassan, 2005, Mechanisms of desensitization of the adrenocorticotropin response to arginine vasopressin in ovine anterior pituitary cells, J. Endocrinol., 184, 29, 10.1677/joe.1.05654 Stokes, 2004, Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms, Nutr. Neurosci., 7, 247, 10.1080/10284150400010012 Noaghiul, 2003, Cross-national comparisons of seafood consumption and rates of bipolar disorders, Am. J. Psychiatry, 160, 2222, 10.1176/appi.ajp.160.12.2222 Tanskanen, 2001, Fish consumption, depression, and suicidality in a general population, Arch. Gen. Psychiatry, 58, 512, 10.1001/archpsyc.58.5.512 Arvindakshan, 2003, Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients, Biol. Psychiatry, 53, 56, 10.1016/S0006-3223(02)01443-9 Evans, 2003, Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment, Prostaglandins Leukot. Essent. Fatty Acids, 69, 393, 10.1016/j.plefa.2003.08.010 Khan, 2002, Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics, Schizophr. Res., 58, 1, 10.1016/S0920-9964(01)00334-6 Reddy, 2004, Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline, Schizophr. Bull, 30, 901, 10.1093/oxfordjournals.schbul.a007140 Assies, 2001, Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group, Biol. Psychiatry, 49, 510, 10.1016/S0006-3223(00)00986-0 Glen, 1994, A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases, Schizophr. Res., 12, 53, 10.1016/0920-9964(94)90084-1 Peet, 1995, Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients, J. Psychiatr Res., 29, 227, 10.1016/0022-3956(95)00001-L Ranjekar, 2003, Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients, Psychiatry Res., 121, 109, 10.1016/S0165-1781(03)00220-8 Adams, 1996, Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression, Lipids, 31, S157, 10.1007/BF02637069 Edwards, 1998, Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients, J. Affect. Disord, 48, 149, 10.1016/S0165-0327(97)00166-3 Frasure-Smith, 2004, Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes, Biol. Psychiatry, 55, 891, 10.1016/j.biopsych.2004.01.021 Maes, 1999, Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients, Psychiatry Res., 85, 275, 10.1016/S0165-1781(99)00014-1 Peet, 1998, Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients, Biol. Psychiatry, 43, 315, 10.1016/S0006-3223(97)00206-0 Chiu, 2003, Polyunsaturated fatty acid deficit in patients with bipolar mania, Eur. Neuropsychopharmacol., 13, 99, 10.1016/S0924-977X(02)00130-X Horrobin, 1991, Fatty acid levels in the brains of schizophrenics and normal controls, Biol. Psychiatry, 30, 795, 10.1016/0006-3223(91)90235-E Hibbeln, 2003, Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder, Biol. Psychiatry, 53, 431, 10.1016/S0006-3223(02)01549-4 Reddy, 2003, Environmental factors and membrane polyunsaturated fatty acids in schizophrenia, Prostaglandins Leukot Essent. Fatty Acids, 69, 385, 10.1016/j.plefa.2003.08.009 Arvindakshan, 2003, Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia, Schizophr. Res., 62, 195, 10.1016/S0920-9964(02)00284-0 Emsley, 2002, Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia, Am. J. Psychiatry, 159, 1596, 10.1176/appi.ajp.159.9.1596 Mellor, 1995, Schizophrenic symptoms and dietary intake of n-3 fatty acids, Schizophr. Res., 18, 85, 10.1016/0920-9964(95)00084-4 Peet, 1996, Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation, Prostaglandins Leukot Essent. Fatty Acids, 55, 71, 10.1016/S0952-3278(96)90148-9 Peet, 2001, Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia, Schizophr. Res., 49, 243, 10.1016/S0920-9964(00)00083-9 Peet, 2002, Study Group, A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms, J. Psychiatr Res., 36, 7, 10.1016/S0022-3956(01)00048-6 Puri, 2000, Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes, Int. J. Clin. Pract., 54, 57, 10.1111/j.1742-1241.2000.tb11844.x Puri, 1998, Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid, Arch. Gen. Psychiatry, 55, 188, 10.1001/archpsyc.55.2.188 Richardson, 1999, Laterality changes accompanying symptom remission in schizophrenia following treatment with eicosapentaenoic acid, Int. J. Psychophysiol, 34, 333, 10.1016/S0167-8760(99)00090-2 Richardson, 2000, Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid, Eur. Neuropsychopharmacol., 10, 189, 10.1016/S0924-977X(00)00068-7 Su, 2001, Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient, Eur. Neuropsychopharmacol., 11, 295, 10.1016/S0924-977X(01)00098-0 Osher, 2005, Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study, J. Clin. Psychiatry, 66, 726, 10.4088/JCP.v66n0608 Frangou, 2006, Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study, Br. J. Psychiatry, 188, 46, 10.1192/bjp.188.1.46 Stoll, 1999, Omega-3 fatty acids and bipolar disorder: a review, Prostaglandins Leukot Essent. Fatty Acids, 60, 329, 10.1016/S0952-3278(99)80008-8 Stoll, 1999, Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial, Arch. Gen. Psychiatry, 56, 407, 10.1001/archpsyc.56.5.407 Nemets, 2002, Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder, Am. J. Psychiatry, 159, 477, 10.1176/appi.ajp.159.3.477 Peet, 2002, A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs, Archn. Genn. Psychiatry, 59, 913, 10.1001/archpsyc.59.10.913 Su, 2003, Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial, Eurn Neuropsychopharmacol., 13, 267, 10.1016/S0924-977X(03)00032-4 Denisov, 1998, Binding of basic peptides to membranes produces lateral domains enriched in the acidic lipids phosphatidylserine and phosphatidylinositol 4,5-bisphosphate: an electrostatic model and experimental results, Biophys. J., 74, 731, 10.1016/S0006-3495(98)73998-0 Glaser, 1996, Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains, J. Biol. Chem., 271, 26187, 10.1074/jbc.271.42.26187 Laux, 2000, GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism, J. Cell Biol., 149, 1455, 10.1083/jcb.149.7.1455 Rauch, 2002, Myristoylated alanine-rich C kinase substrate (MARCKS) sequesters spin-labeled phosphatidylinositol 4,5-bisphosphate in lipid bilayers, J. Biol. Chem., 277, 14068, 10.1074/jbc.M109572200 Wang, 2001, The effector domain of myristoylated alanine-rich C kinase substrate binds strongly to phosphatidylinositol 4,5-bisphosphate, J. Biol. Chem., 276, 5012, 10.1074/jbc.M008355200 Wang, 2002, Lateral sequestration of phosphatidylinositol 4,5-bisphosphate by the basic effector domain of myristoylated alanine-rich C kinase substrate is due to nonspecific electrostatic interactions, J. Biol. Chem., 277, 34401, 10.1074/jbc.M203954200 Jin, 2003, SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain, J. Neurochem., 85, 378, 10.1046/j.1471-4159.2003.01698.x McNamara, 2005, Locomotor activity induced by selective activation of phosphoinositide-linked dopamine D1-like receptors: Modulation by gene background, brain fatty acid composition, and chronic lithium, Soc. Neurosci. Abstracts, 35, 342 Cabib, 1998, Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems, Neuroscience, 84, 193, 10.1016/S0306-4522(97)00468-5 McNamara, 2003, Differential expression and regulation of myristoylated alanine-rich C kinase substrate (MARCKS) in the hippocampus of C57/BL6J and DBA/2J mice, J. Neurochem., 85, 462, 10.1046/j.1471-4159.2003.01700.x Cao, 1997, Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees, Genomics, 43, 1, 10.1006/geno.1997.4815 Schulze, 2004, Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees, Biol. Psychiatry, 56, 18, 10.1016/j.biopsych.2004.04.004 Gerber, 2003, Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit, Proc. Natl. Acad. Sci. USA, 100, 8993, 10.1073/pnas.1432927100 Eastwood, 2005, Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia, Biol. Psychiatry, 57, 702, 10.1016/j.biopsych.2004.12.029 Rushlow, 2005, Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics, J. Neurochem., 94, 587, 10.1111/j.1471-4159.2005.03092.x Miyakawa, 2003, Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia, Proc. Natl. Acad. Sci. USA, 100, 8987, 10.1073/pnas.1432926100 Dawson, 1995, Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder, Psychiatr Genet., 5, 177, 10.1097/00041444-199524000-00005 Jacobsen, 1999, Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder, Mol. Psychiatry, 4, 274, 10.1038/sj.mp.4000476 Papadimitriou, 2003, Genetic association between the phospholipase A2 gene and unipolar affective disorder: a multicentre case-control study, Psychiatr. Genet., 13, 211, 10.1097/00041444-200312000-00004 Pae, 2004, BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia, Prog. Neuropsychopharmacol Biol. Psychiatry, 28, 739, 10.1016/j.pnpbp.2004.05.009 Gattaz, 1987, Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy, Biol. Psychiatry, 22, 421, 10.1016/0006-3223(87)90164-8 Gattaz, 1990, Increased serum phospholipase A2 activity in schizophrenia: a replication study, Biol. Psychiatry, 28, 495 Noponen, 1993, Elevated PLA2 activity in schizophrenics and other psychiatric patients, Biol. Psychiatry, 34, 641, 10.1016/0006-3223(93)90157-9 Ross, 1997, Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2, Arch. Gen. Psychiatry, 54, 487, 10.1001/archpsyc.1997.01830170113015 Ross, 1999, Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia, Brain Res., 821, 407, 10.1016/S0006-8993(99)01123-3 Martin, 1998, Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells, J. Neurosci. Res., 54, 805, 10.1002/(SICI)1097-4547(19981215)54:6<805::AID-JNR8>3.0.CO;2-4 Husain, 1998, Role of protein kinase C alpha in endothelin-1 stimulation of cytosolic phospholipase A2 and arachidonic acid release in cultured cat iris sphincter smooth muscle cells, Biochim. Biophys. Acta., 1392, 127, 10.1016/S0005-2760(98)00011-3 Nemenoff, 1993, Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C, J. Biol. Chem., 268, 1960, 10.1016/S0021-9258(18)53948-X Xing, 1997, Dual role of protein kinase C in the regulation of cPLA2-mediated arachidonic acid release by P2U receptors in MDCK-D1 cells: involvement of MAP kinase-dependent and -independent pathways, J. Clin. Invest., 99, 805, 10.1172/JCI119227 Xu, 2002, Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes, J. Neurochem., 83, 259, 10.1046/j.1471-4159.2002.01145.x Carrie, 2000, Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice, J. Lipid Res., 41, 473, 10.1016/S0022-2275(20)34486-2 DeMar, 2006, One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats, J. Lipid Res., 47, 172, 10.1194/jlr.M500362-JLR200 Greiner, 2001, Olfactory discrimination deficits in n-3 fatty acid-deficient rats, Physiol. Behav., 72, 379, 10.1016/S0031-9384(00)00437-6 Wainwright, 1998, Effects of dietary n-3 deficiency on amphetamine-conditioned place preference and working memory in the Morris water-maze, Nutr. Neurosci., 4, 281, 10.1080/1028415X.1998.11747238 Levant, 2004, Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation, Behav. Brain Res., 152, 49 Ahmad, 2002, Decrease in neuron size in docosahexaenoic acid-deficient brain, Pediatr. Neurol., 26, 210, 10.1016/S0887-8994(01)00383-6 Ahmad, 2002, A decrease in cell size accompanies a loss of docosahexaenoate in the rat hippocampus, Nutr. Neurosci., 5, 103, 10.1080/10284150290018973 Calderon, 2004, Docosahexaenoic acid promotes neurite growth in hippocampal neurons, J. Neurochem., 90, 979, 10.1111/j.1471-4159.2004.02520.x Babcock, 2002, Modulation of lipopolysaccharide-stimulated tumor necrosis factor-α production by omega-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10, J. Surg. Res., 107, 135 R.K. McNamara, S.E. Carlson, Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fatty Acids, in press, doi:10.1016/j.plefa.2006.07.010.